^™middle.

Gathering signals...

Anatara Lifesciences (ASX:ANR) — Material Events

ASX:ANR · 8 articles in the last 12 months · 100% assessed

Click a band to jump to that tier

Major ≥90 Significant 75–89 Notable 50–74 Routine <50 Not assessed

Significant Score 75–89

1

Anatara Lifesciences Unveils Promising Anti-Obesity Compound Amid $1.2M Capital RaiseMedium

Anatara Lifesciences reports promising anti-obesity pre-clinical results and completes $1.2M capital raise

30 Jan 2026 ·Quarterly Activities Report & Appendix 4C ·75

Notable Score 50–74

7

Anatara Lifesciences Advances Anti-Obesity Trials, Secures $1.2M PlacementMedium

Anatara Lifesciences advances Anti-Obesity and GaRP projects, announces board change and $1.2m placement

23 Oct 2025 ·Quarterly Activities Report and Appendix 4C ·70

Anatara’s AOC Compound Shows Promise in Pre-Clinical Weight Control StudyMedium

Anatara reports positive pre-clinical anti-obesity results; MOA study delayed to January 2026

17 Dec 2025 ·Company Update ·70

Anatara Lifesciences Finalises 66 Million Share Placement, Issues Options to Lead ManagerMedium

Anatara Lifesciences completes Tranche 2 placement of 66.35 million shares and issues options to Lead Manager

26 Nov 2025 ·Capital Raising ·70

Anatara Lifesciences Halves Loss, Advances Anti-Obesity Research Amid $1.2m Capital RaiseMedium

Anatara Lifesciences halves net loss, advances anti-obesity pre-clinical studies, completes $1.2m capital raise

25 Feb 2026 ·Appendix 4D and Interim Financial Report ·70

Anatara Lifesciences Secures $1.2m to Advance Anti-Obesity ProgramMedium

Anatara Lifesciences raises $1.2m via discounted placement to fund Anti-Obesity project

1 Oct 2025 ·Capital Raising ·70

Anatara Lifesciences Navigates Mixed Anti-Obesity Data and Tight Cash PositionMedium

Anatara Lifesciences reports mixed Anti-Obesity preclinical results, plans Phase 1 study, cash at $0.7M

29 Apr 2026 ·Quarterly Activities and Appendix 4C Cash Flow Report ·60

Anatara Lifesciences Issues 33.6 Million Shares in First Placement TrancheMedium

Anatara Lifesciences issues 33.6 million shares in first tranche placement

8 Oct 2025 ·Capital Raising ·60

Not Assessed Low Score, or missing data

0

No articles in this tier for the last 12 months.

Market Mentions 2 - appeared in market wrap coverage

These are market wrap articles where Anatara Lifesciences (ASX:ANR) was mentioned. They reflect broader market coverage, not company-specific announcements.

Healthcare Wrap - Week 18 (27 Apr -> 1 May) 2026

Healthcare Wrap - Week 9 (23 Feb -> 27 Feb) 2026